Patents by Inventor Debborah Maguire

Debborah Maguire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolated peptide or polypeptide of the extracellular portion of the human interferon receptor (IFN-R).
    Patent number: 6787634
    Abstract: A monoclonal antibody is provided which is directed against the human interferon type I receptor (IFN-R), which recognizes the extracellular domain of the human IFN-R and which has neutralizing capacity against the biological properties of human type I-IFN. Diagnostic and therapeutic applications for the monoclonal antibody also are provided.
    Type: Grant
    Filed: February 2, 1999
    Date of Patent: September 7, 2004
    Assignee: Medisup International, N.V.
    Inventors: Patrick Benoit, Francois Meyer, Debborah Maguire, Ivan Plavec, Michael G. Tovey
  • MONOCLONAL ANTIBODIES AGAINST THE INTERFERON RECEPTOR, WITH NEUTRALIZING ACTIVITY AGAINST TYPE 1 INTERFERON
    Publication number: 20020055492
    Abstract: A monoclonal antibody is provided which is directed against the human interferon type I receptor (IFN-R), which recognizes the extracellular domain of the human IFN-R and which has neutralizing capacity against the biological properties of human type I-IFN. Diagnostic and therapeutic applications for the monoclonal antibody also are provided.
    Type: Application
    Filed: February 2, 1999
    Publication date: May 9, 2002
    Inventors: PATRICK BENOIT, FRANCOIS MEYER, DEBBORAH MAGUIRE, IVAN PLAVEC, MICHAEL G. TOVEY
  • Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
    Patent number: 5919453
    Abstract: A monoclonal antibody directed against the human interferon type I receptor (IFN-R), which recognizes the extracellular domain of the human IFN-R and has neutralizing capacity against the biological properties of human type I-IFN. Diagnostic applications for the monoclonal antibody also are provided.
    Type: Grant
    Filed: December 5, 1994
    Date of Patent: July 6, 1999
    Assignee: Laboratoire European De Biotechnologie S.A.
    Inventors: Patrick Benoit, Francois Meyer, Debborah Maguire, Ivan Plavec, Michael G. Tovey